Novonesis A S (NVZMF) Q1 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Ladies and gentlemen, welcome to the Novonesis Q1 2026 conference call. I'm Lorenzo, the chorus call operator. I would like to remind you that all participants will be in listen-only mode and the conference is being recorded. The presentation will be followed by a Q&A session. You can register for questions at any time by pressing star and 1 on your telephone. For operator assistance, please press star and 0. The conference must not be recorded for publication or broadcast. At this time, it's my pleasure to hand over to Tobias Cornelius Björklund. Please go ahead. Thank you very much, operator, and welcome everyone to NovoNesis conference call for the first quarter of 2026. As mentioned, my name is Tobias Björklund, and I'm heading up investor relations here at NovoNesis. In this call, our CEO, Esther Baggett, and our CFO, Reino Lehmann, will review our performance as well as the outlook for 2026. Also attending today's call, we have Tina Feiner, EVP of Planetary Health Biosolutions. We have Henrik Jörg Nilsson, EVP of Human Health Biosolutions. Andrew Taylor, EVP of Food and Beverages Biosolutions. And Klaus-Krone Fuglsang, Chief Scientific Officer. The conference call will take about 50 minutes, including Q&A. Let's change to the next slide. As usual, I would like to remind you that the information presented during the call is unaudited and that management may make forward-looking statements. These statements are based on current expectations and beliefs, and they involve risks and uncertainties that could cause actual results to differ materially from those described in any forward-looking statement. With that, I will now hand you over to our CEO, Esther Bachett. Esther, please. Thank you. Thank you, Tobias, and welcome, everyone. Thank you for joining us this mor...